BCDA - BioCardia, Inc.
2.65
0.220 8.302%
Share volume: 45,685
Last Updated: 05-07-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$2.43
0.22
0.09%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-14-2024 | 08-09-2023 | 11-08-2023 | 11-13-2024 | 05-14-2024 | 08-13-2024 | 11-13-2024 | 03-26-2025 | |
| Total revenue | 64.000 K | 43.000 K | 357.000 K | 13.000 K | 55.000 K | 3.000 K | 0.000 | -58.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 64.000 K | 43.000 K | 357.000 K | 13.000 K | 55.000 K | 3.000 K | 0.000 | -58.000 K | |
| -32.81% | 730.23% | -96.36% | 323.08% | -94.55% | -100.00% | inf% | |||
| Operating expenses | 3.574 M | 3.495 M | 2.955 M | 2.097 M | 2.330 M | 1.652 M | 1.756 M | 2.321 M | |
| Selling general and admin | 1.190 M | 1.181 M | 1.083 M | 941.000 K | 1.089 M | 852.000 K | 825.000 K | 906.000 K | |
| Research and development | 2.384 M | 2.314 M | 1.872 M | 1.156 M | 1.241 M | 800.000 K | 931.000 K | 1.415 M | |
| Total expenses | 3.574 M | 3.495 M | 2.955 M | 2.097 M | 2.330 M | 1.652 M | 1.756 M | 2.321 M | |
| -2.21% | -15.45% | -29.04% | 11.11% | -29.10% | 6.30% | 32.18% | |||
| Operating income | -3.510 M | -3.452 M | -2.598 M | -2.084 M | -2.275 M | -1.649 M | -1.756 M | -2.321 M | |
| Ebit | -3.510 M | -3.424 M | -2.598 M | -2.084 M | -2.267 M | -1.649 M | -1.737 M | -2.321 M | |
| Pretax income | -3.510 M | -3.424 M | -2.598 M | -2.136 M | -2.267 M | -1.649 M | -1.737 M | -2.293 M | |
| -2.45% | -24.12% | -17.78% | 6.13% | -27.26% | 5.34% | 32.01% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -3.501 M | -3.424 M | -2.574 M | -2.072 M | -2.267 M | -1.646 M | -1.737 M | -2.296 M | |
| 2.20% | 24.82% | 19.50% | -9.41% | 27.39% | -5.53% | -32.18% |
